Which of the following neurotransmitters has been most consistently implicated in the patient's disorder?

Questions 105

ATI RN

ATI RN Test Bank

Central and Peripheral Nervous System Drugs Questions

Question 1 of 5

Which of the following neurotransmitters has been most consistently implicated in the patient's disorder?

Correct Answer: A

Rationale: The correct answer is A: Acetylcholine. Acetylcholine is most consistently implicated in disorders like Alzheimer's disease due to its role in memory and cognitive functions. Dysfunction in acetylcholine signaling is a hallmark of this disorder. Norepinephrine is primarily involved in the stress response, GABA in regulating anxiety, and serotonin in mood regulation. However, acetylcholine's direct association with cognitive impairment makes it the most likely neurotransmitter involved in the patient's disorder.

Question 2 of 5

Which of the following drugs has the highest potency among the new potential inhalational anesthetics tested in laboratory animals?

Correct Answer: D

Rationale: The correct answer is D: Drug S. Potency refers to the amount of drug needed to produce a specific effect. Drug S has the highest potency among the options because it requires the smallest dose to achieve the desired effect compared to Drugs P, Q, and R. In laboratory testing, Drug S consistently showed a strong and rapid onset of action at lower doses, making it the most potent inhalational anesthetic among the options. Drug S is therefore the correct choice for having the highest potency. Choices A, B, and C are incorrect because they do not exhibit the same level of potency as Drug S based on the laboratory testing results.

Question 3 of 5

Which of the following variables most likely caused the decrease in MAC in this case?

Correct Answer: D

Rationale: The correct answer is D: The addition of nitrous oxide. Nitrous oxide is known to decrease minimum alveolar concentration (MAC) of anesthetic agents, leading to a lower concentration needed to maintain anesthesia. This is due to its anesthetic properties and synergistic effects with other anesthetics. Choice A (cancer) and C (age) are unlikely to directly affect MAC levels. Choice B (use of two anesthetics) might actually increase MAC rather than decrease it, making it an incorrect choice.

Question 4 of 5

Which of the following adverse effects would most likely occur after the administration of another dose of lidocaine near the brachial plexus for a peripheral nerve block?

Correct Answer: D

Rationale: The correct answer is D: Convulsions. Lidocaine is a local anesthetic that can cause central nervous system toxicity, leading to symptoms like seizures or convulsions. When administered near the brachial plexus for a peripheral nerve block, lidocaine can inadvertently reach systemic circulation, increasing the risk of CNS side effects. Ventricular tachycardia (A) is a cardiac adverse effect, not commonly associated with lidocaine toxicity. Abdominal colic (B) is unrelated to lidocaine administration near the brachial plexus. Drowsiness (C) is a common systemic side effect of lidocaine but is less likely to occur after administration near the brachial plexus compared to CNS effects like convulsions.

Question 5 of 5

Which drug would most likely be effective in decreasing the patient's spontaneous breathing?

Correct Answer: B

Rationale: The correct answer is B: Vecuronium. Vecuronium is a non-depolarizing neuromuscular blocking agent that inhibits acetylcholine from binding to nicotinic receptors, leading to muscle paralysis including respiratory muscles, thus decreasing spontaneous breathing. Diazepam (A) is a benzodiazepine that acts on the central nervous system but does not directly affect respiratory muscles. Botulinum toxin (C) blocks acetylcholine release at the neuromuscular junction but is not suitable for systemic use to decrease spontaneous breathing. Dantrolene (D) is a muscle relaxant that acts on skeletal muscles but does not directly inhibit respiratory muscles.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions